The Intersection Of RNA, AI, And Synthetic Biology With Shape Therapeutics' Dr. Francois Vigneault

<p>Dr. Francois Vigneault, Co-Founder, President, and CEO at Shape Therapeutics joins Cell &amp; Gene: The Podcast&apos;s Erin Harris to discuss how RNA technologies are shaping the future of gene therapy. They also discuss AI&apos;s role in gene therapy as well as the how the CGT sector is benefiting from RNA, AI, and synthetic biology.</p>